Ohnmacht, Jochen
May, Patrick
Sinkkonen, Lasse
Krüger, Rejko
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg (FNR/P13/6682797)
Fonds National de la Recherche Luxembourg (12719684)
Fonds National de la Recherche Luxembourg (C17/BM/11676395)
Fonds National de la Recherche Luxembourg (C17/BM/11676395)
Fonds National de la Recherche Luxembourg (C15/BM/10406131)
Fonds National de la Recherche Luxembourg (NCER-PD)
Fonds National de la Recherche Luxembourg (NCER-PD)
EU Joint Programme – Neurodegenerative Disease Research (COURAGE-PD)
EIT Health (692320)
Bundesministerium für Bildung und Forschung (Mito-PD 031 A 430 A)
Article History
Received: 27 February 2020
Accepted: 24 March 2020
First Online: 4 April 2020
Compliance with ethical standards
:
: RK serves as Editorial Board Member of the Journal of Neural Transmission, the European Journal of Clinical Investigation and the Journal of Parkinsonism and Related Disorders. RK received speaker’s honoraria and/or travel grants from Abbvie, Zambon and Medtronic and he participated as PI or site-PI for industry-sponsored clinical trials without receiving honoraria. The other authors declare no competing interests.